Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. - Wikidata - wikimedia - TriplyDB

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q33988009

about

Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer Adjuvant chemotherapy for resected early-stage non-small cell lung cancer Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value Post-operative radiation therapy Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis Systemic and targeted therapies for early-stage lung cancer 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer 50 Years of progress in the systemic therapy of non-small cell lung cancer Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer Prognostic value of microRNA expression in operable non-small cell lung cancer patients Predictive and prognostic molecular markers for cancer medicine Lung cancer in Brazil: epidemiology and treatment challenges.Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.Multigene expression-based predictors for sensitivity to Vorinostat and Velcade in non-small cell lung cancer.Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.Prognostic gene signatures for non-small-cell lung cancer.Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1.A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

P2860

Q21092374-84177538-4936-45DF-9CD3-0D034739C350 Q24187439-A67DB415-49C2-4766-9B32-E0CDFEF2B5D0 Q24604495-2081121A-7C52-4EC2-B9B7-4F5C9B336ABC Q24633254-DB607773-65F2-4CF8-9CB9-5C1F4FE2CCC5 Q26748296-C7D6777A-BCA2-4CF3-B054-3583214CBC68 Q26829425-CEA45475-E7A6-45FB-9260-A45C876A3F6A Q26830376-E53C0637-7E3F-480F-B67A-68CB8A06A836 Q26859343-83676B0C-C36E-44DC-BF07-62F7C51FF603 Q26865490-D71D0EB4-8B37-4B06-8265-9FF32844879C Q27002509-F6858BC8-9661-492A-BA01-8A04A5BC5EAD Q27014978-9EF7508D-A87E-49A4-B4C1-28D62E36536E Q27313799-037117BD-70F3-40BD-BC61-81C7FF7E1742 Q27851448-0A7E17A9-52F8-41E4-916D-1F04D4234478 Q27853293-7EEEBEC1-F13E-407C-8FA8-442F6D877596 Q28080636-3A0A9167-1C9C-47FF-A1AF-1ECE16197048 Q28209997-1FED0751-4859-44E0-8172-86CBE8B9624C Q28265589-FDFD430B-638E-412D-895E-6249F75D1F3F Q28278682-58A566DC-A31D-49ED-9612-C9E40568512A Q28394974-54C0D23F-5C06-425A-97A6-B80DAB5A502F Q28396343-DABAF258-DC87-468D-B5EF-934BD85447D5 Q28743108-41C10958-4C5B-4A8C-A98E-05633E263B80 Q30235908-6EA453F3-8C37-43FB-AA4D-E36E17C3DE5D Q30358684-E093DC8C-F040-4F7C-9E5D-F992DCA43D42 Q30430515-3CEA7CB3-32CD-40C6-B3EB-2CD97233C18A Q30438068-A91ADCDF-8C0A-4CBE-BFCF-00792E95CFD3 Q30439235-13F4C8C1-8829-47CC-95EF-2D1C92A015BA Q30485836-E2E28AAC-24B4-4520-ACEF-2F56057D899E Q30487266-B006B43C-E3BD-42EA-8427-7D133A70B95E Q30497419-C5D4C2F4-C926-4FBF-8869-A51F33C3DC25 Q30498101-E4C881FA-15CF-4E5A-AE11-B6A280F60F03 Q30503151-D858281C-6D4B-4463-9A15-1B8E70FA4148 Q30539299-7496C199-2E9E-4790-9FAF-3978831E92A6 Q30580553-49E052B7-9743-4215-B375-45D8F65E64D6 Q30645831-9B180268-AD21-44EF-BD17-70906A357A32 Q30742035-18D665AE-DD56-48E3-91FE-E9D082835AED Q30833946-6EE8BB20-64BB-4429-BE00-687E6D052DDF Q30868582-E0DD9401-D654-450A-AF8F-A0E512CECDBF Q30976026-50E17028-295B-44A1-B75D-A57AD6CAEC7E Q31036733-2D86C504-7B69-4C96-BF36-F945FFC47A25 Q33241239-4942771B-8878-4CF3-80BB-F71168E5D4A1

P2860

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q33988009

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@ast

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@en

type

label

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@ast

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@en

prefLabel

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@ast

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@en

P1433

Q33988009-C632302D-85BD-49D0-90F9-621C6305EC6B

P1476

Q33988009-7BDE6416-2683-4A46-AA12-58A151C26C61

P2093

Q33988009-00508DE7-130F-45F9-8BE8-99DDBBD0479F

Q33988009-222DE3D2-690E-4442-9B24-B9EDEE4C6729

Q33988009-29AD69A2-4CD1-4474-AB22-C5AAF6D389CD

Q33988009-3EDCC124-DABC-4B85-B1C9-B5DD66461CBE

Q33988009-566327C8-53AA-45F4-80E2-33597EAC2219

Q33988009-6B0D2516-5187-42FF-A082-578A9F2748D9

Q33988009-89C803FE-26C2-4892-AB86-A19AA26A2FAC

Q33988009-8A8DA227-7001-4652-889D-CC8635B103B7

Q33988009-8C620B83-B536-4369-9A94-0CC79C2EDC31

Q33988009-9EEFCF53-A4BC-47AB-B47A-CD43D74FEABE

P304

Q33988009-869EBAB4-7566-45AB-AAD4-96BC499B4244

P31

Q33988009-C6E28B79-328A-4546-9C29-5ACA450FBF2A

P356

Q33988009-ED22D4D0-7085-4608-91F9-BC00E5042721

P407

Q33988009-7882E744-DAC7-4783-A662-CBDB538C9414

P433

Q33988009-3A3B6793-4D5D-466D-A42E-A28AF1F39A6E

P478

Q33988009-8750B7B5-D5DC-454A-8ED6-8DB3DEB71F35

P50

Q33988009-0F9869B7-BF83-497D-85E5-B9697E0C4932

Q33988009-2DE02CAE-04A9-4E8A-97E6-584331A422E7

Q33988009-580E62E3-0FE7-4A2B-B0DF-52D849786DC9

Q33988009-C50E6341-173C-48F1-805F-52A5C09F1F6A

P577

Q33988009-BCB62C0D-8FB1-4E2A-BDCB-CF7A57D354CE

P698

Q33988009-107EA459-CF8C-4107-B62D-5EEBEAE1B249

P356

P1433

The New England Journal of Medicine

P1476

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

@en

P2093

Barbara Graham

http://www.w3.org/2001/XMLSchema#string

Charles Butts

http://www.w3.org/2001/XMLSchema#string

David Johnson

http://www.w3.org/2001/XMLSchema#string

Drew Bethune

http://www.w3.org/2001/XMLSchema#string

Frances Shepherd

http://www.w3.org/2001/XMLSchema#string

Glenwood Goss

http://www.w3.org/2001/XMLSchema#string

James Rigas

http://www.w3.org/2001/XMLSchema#string

Joseph Ayoub

http://www.w3.org/2001/XMLSchema#string

Kenneth Kesler

http://www.w3.org/2001/XMLSchema#string

Keyue Ding

http://www.w3.org/2001/XMLSchema#string

P304

2589-2597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA043623

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Ming-Sound Tsao

National Cancer Institute of Canada Clinical Trials Group

David R Gandara

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15972865

http://www.w3.org/2001/XMLSchema#string